Want to see VIR full AI Analyst Report?
Vir Biotechnology (VIR) Stock Forecast & Price Target
VIR Analyst Ratings
VIR Stock 12 Month Forecast
Average Price Target
$20.35▲(66.64% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Alec Stranahan | Bank of America Securities | $15→$17 | buy | 39.23%Upside | Reiterated | 11/06/26 | ||
| Etzer Darout | Barclays | $30 | buy | 145.70%Upside | Reiterated | 11/05/26 | ||
| Michael Ulz | Morgan Stanley | $25 | buy | 104.75%Upside | Assigned | 11/05/26 | ||
| Phil Nadeau | TD Cowen | $11.77 | buy | -3.60%Downside | Reiterated | 11/05/26 | ||
| Roanna Ruiz | Leerink Partners | $17 | buy | 39.23%Upside | Reiterated | 11/05/26 | ||
| Cory Kasimov | Evercore ISI | $22 | buy | 80.18%Upside | Reiterated | 11/05/26 | ||
| Patrick Trucchio | H.C. Wainwright | $22 | buy | 80.18%Upside | Reiterated | 11/04/26 | ||
| Joseph Stringer | Needham | $18 | buy | 47.42%Upside | Reiterated | 09/28/26 | ||
| Paul Choi | Goldman Sachs | $21 | buy | 71.99%Upside | Reiterated | 05/06/26 | ||
| Sean McCutcheon | Raymond James | $12→$19 | buy | 55.61%Upside | Reiterated | 02/24/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Alec StranahanBank of America Securities | BuyReiterated$15→$17 | 11/06/26 | 39.23%Upside | ||
| Etzer DaroutBarclays | BuyReiterated$30 | 11/05/26 | 145.70%Upside | ||
| Michael UlzMorgan Stanley | BuyAssigned$25 | 11/05/26 | 104.75%Upside | ||
| Phil NadeauTD Cowen | BuyReiterated$11.77 | 11/05/26 | -3.60%Downside | ||
| Roanna RuizLeerink Partners | BuyReiterated$17 | 11/05/26 | 39.23%Upside | ||
| Cory KasimovEvercore ISI | BuyReiterated$22 | 11/05/26 | 80.18%Upside | ||
| Patrick TrucchioH.C. Wainwright | BuyReiterated$22 | 11/04/26 | 80.18%Upside | ||
| Joseph StringerNeedham | BuyReiterated$18 | 09/28/26 | 47.42%Upside | ||
| Paul ChoiGoldman Sachs | BuyReiterated$21 | 05/06/26 | 71.99%Upside | ||
| Sean McCutcheonRaymond James | BuyReiterated$12→$19 | 02/24/26 | 55.61%Upside |
Best Analysts Covering Vir Biotechnology
Copying Patrick Trucchio's trades and holding each position for 3 Months would result in 70.59% of your transactions generating a profit, with an average return of +11.01% per trade.
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +44.02% per trade.
Copying Patrick Trucchio's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +66.26% per trade.
VIR Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 14 | 10 | 10 | 14 | 12 |
| Buy | 2 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 16 | 11 | 11 | 15 | 14 |
In the current month, VIR has received 14 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VIR average Analyst price target in the past 3 months is 20.35.
VIR Financial Forecast
VIR Earnings Forecast
Next quarter’s earnings estimate for VIR is -$0.32 with a range of -$0.72 to $0.09. The previous quarter’s EPS was -$0.57. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
VIR Sales Forecast
Next quarter’s sales forecast for VIR is $40.35M with a range of $100.00K to $90.00M. The previous quarter’s sales results were -$188.00K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
